Clinical trial
Insulin Glulisine in Adult Subjects With Type 2 Diabetes Receiving Insulin…
NCT00135057 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00135057 |
|---|---|
| Title | Insulin Glulisine in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal Insulin |
| Official title | Insulin Glulisine Administered in a Fixed Bolus Regimen Versus Variable Bolus Regimen Based on Carbohydrate Counting in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal Insulin |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | insulin glulisine, insulin glargine |
| Enrollment | 281 |
| Start date | Apr 1, 2004 |
| Completion | Aug 1, 2005 |
| First posted | Aug 25, 2005 |
| Last update posted | Jan 11, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: